Published • loading... • Updated
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about to break: the next frontier isn’t a single, more capable…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck
VentureBeat: Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck. “For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about to break: the next frontier isn’t a single, more capable…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
